Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA ...

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

Childhood vaccines may be unsafe because few if any have been tested in placebo-controlled trials before being approved. But ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

A historical review in Vaccine warns that global H2N2 immunity has sharply declined since the 1957 Asian influenza pandemic, ...

Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) - Topline data expected by the end of Q1 2028 as per planPhase 1 data from TG4050 in head and neck cancer published ...

Vietnam plans to join international clinical trials of mRNA-based cancer vaccines and other next-generation vaccines starting ...

A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...

With flu season almost upon us, it’s time to get vaccinated. And for the first time, there’s more than one option available.